Answers are grounded in this paper and cite their sources.
The development of new multianalyte biosensors that can detect multiple classes of biomolecules is highly desirable and will greatly improve medical diagnostics. In the field of infectious diseases, for example, it is beneficial to detect pathogens via nucleic acid analysis together with host immune response markers. In this work, we present a multianalyte-compatible lysis using antimicrobial peptides (AMPs). This strategy enables the simultaneous detection of bacterial DNA and inflammatory biomarkers via multianalyte lateral flow immunoassay (LFIA).
No takes yet. Share an insight, caveat, or question.
Klebes et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: